Market Newsdesk

First Products to Hit California Shelves in Q2 2021
 

PHOENIX, AZ, Nov. 24, 2020 /PRNewswire/ – 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company“) is pleased to announce that its fully funded state of the art 185,000 square foot production facility in Commerce, California is nearing completion and will be ready to serve the $3bCalifornia cannabis market in Q2 2021. The project is on target to be completed in April 2021 with the Company planning for the first of its full line of edibles, tinctures and vape products to be on California retail shelves by May.

Leveraging the market dominating best practices of its Washington facilities, 4Front has successfully introduced its products and brands into Massachusetts, Illinois and soon to be California. The automated state of the art Commerce facility incorporates unprecedented capacity for finished goods manufacturing, similar to the scale seen in the traditional consumer packaged goods industry. Commerce will have the ability to produce over ten times the current capacity of 4Front’s 40,000 square foot Washington production hub, which is currently the number one producer of derivative cannabis products in Washington State.

The successful closing of a C$17.25 million bought deal financing provides the Company with all it needs to finish the California facility and to replicate its proven high quality /low-cost production strategy that has been so successful in even the most competitive of cannabis markets such as Washington State. 

“We’re thrilled to be in California and to be completing our largest and most automated manufacturing facility yet,” stated Leo Gontmakher, Chief Executive Officer of 4Front. “Our experience in Washington, Massachusetts and Illinois, where we excel in low-cost manufacturing at scale, uniquely positions us to successfully compete in one of the largest, if not the largest, cannabis markets in the world.” 

Mr. Gontmakher continued, “This facility is almost finished and with our large-scale customized production line will produce a minimum of ten times more product per shift than the largest of our other locations. I am not aware of a production facility in the country which will rival us in either size or efficiency and we are poised to attack the California market in a manner that the rest of the industry has been unable to do. 

“In short,” said Gontmakher, “this facility is expected to produce quality product at scale and at a price point that pleases both retailer and consumer.  Being the lowest cost producer is our strategy for every state in which we operate, and I am excited to soon announce further capacity expansions in Illinois and Massachusetts as well.”

To receive company updates and be added to the email distribution list please sign up here.

About 4Front Ventures Corp.

4Front (CSE: FFNT) (OTCQX: FFNTF) is a national multi-state cannabis operator and retailer, with a market advantage in mass-produced, low-cost quality branded cannabis products. 4Front manufactures and distributes a portfolio of over 25 cannabis brands including Marmas, Crystal Clear, Funky Monkey, Pebbles, and the Pure Ratios wellness collection, distributed through retail outlets and their chain of strategically positioned Mission branded dispensaries.

Headquartered in Phoenix, Arizona, 4Front has operations in Illinois, Massachusetts, California, Michigan and Washington state. From plant genetics to the cannabis retail experience, 4Front’s team applies expertise across the entire cannabis value chain. For more information, visit 4Front’s website.

This news release was prepared by management of 4Front Ventures, which takes full responsibility for its contents. The Canadian Securities Exchange (“CSE”) has not reviewed and does not accept responsibility for the adequacy of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in 4Front Ventures’ periodic filings with securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements. 

Forward-looking statements may include, without limitation, statements related to future developments and the business and operations of 4Front, developments with respect to the Commerce facility including the expected timeline for construction and opening and the capacity and capabilities of the facility, use of proceeds from the Offering and expectations with respect to the full funding of the facility from such proceeds,

 

and other statements regarding future developments of the business.

Although 4Front Ventures has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in projects which have limited or no operating history and are engaged in activities currently considered illegal under U.S. federal laws; factors related to the COVID-19 pandemic; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry; and regulatory or political change, as well as the factors identified in the “Risk Factors” section of the Prospectus.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. 4Front disclaims any intention or obligation to update or revise such information, except as required by applicable law.

View original content to download multimedia:http://www.prnewswire.com/news-releases/4front-ventures-to-complete-185-000-square-foot-manufacturing-facility-in-commerce-california-301179383.html

SOURCE 4Front

CAMBRIDGE, Mass., Nov. 24, 2020 /PRNewswire/ — Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will participate in the Piper Sandler 32^nd Annual Virtual Healthcare Conference.

John P. Butler, President and Chief Executive Officer, and David A. Spellman, Senior Vice President and Chief Financial Officer, will participate in virtual one-on-one meetings on Thursday, December 3, 2020.

A recording of Akebia’s conference presentation is available via the Piper Sandler conference site as well as on the Investors section of the Company’s website at https://ir.akebia.com, from November 24 to December 3, 2020. 

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact

Kristen K. Sheppard, Esq.

[email protected] 

View original content to download multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-to-participate-in-piper-sandler-32nd-annual-virtual-healthcare-conference-301179379.html

SOURCE Akebia Therapeutics

LOVELAND, Colo., Nov. 24, 2020 /PRNewswire/ — Heska Corporation (NASDAQ: HSKA – News; “Heska” or the “Company”), a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska’s President & Chief Executive Officer, will participate in the Piper Sandler 32^nd Annual Virtual Healthcare Conference on Tuesday, December 1, 2020.

Mr. Wilson’s fireside presentation with Piper Sandler will be available for registered attendees on the Piper Sandler conference site from November 23 to December 3. The webcast will be archived and a replay will be available on the Company’s website for 90 days following the conference. 

Mr. Wilson and members of Heska management will be participating in one-on-one meetings on December 1.  Meetings may be requested via Piper Sandler or Heska Investor Relations at [email protected].

About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/heska-corporation-to-present-at-the-upcoming-piper-sandler-32nd-annual-virtual-healthcare-conference-301179500.html

SOURCE Heska Corporation

DAVIS, Calif., Nov. 24, 2020 /PRNewswire/ — Arcadia Biosciences, Inc.^®(Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced it has signed a distribution agreement with Tritium 3H, Inc. (T3H), a Canadian hemp seed company based in Lethbridge, Alberta, that specializes in hemp field testing, certified seed production, commercialization and distribution of industrial hemp varieties for the Canadian market.

T3H will distribute Arcadia’s GoodHemp seed varieties and genetics in Canada once they have been certified by the Association of Official Seed Certifying Agencies (“AOSCA”) and Health Canada. The initial varieties distributed will include:

• Umpqua: CBD dominant, early photoperiod variety for both the smokable and CBD extraction markets. Prized for its unique terpene profile.
• Rogue: CBD dominant, high yielding intermediate photoperiod variety for the CBD extraction markets. Brings exceptional yields under low planting densities.
• Santiam: CBD dominant, early photoperiod variety with exceptional utility in northern latitudes for both the smokable and CBD extraction markets. Delivers step change yield potential.

Said Arcadia CEO Matt Plavan, “This agreement solidifies our plans to accelerate the commercialization of Arcadia’s hemp genetics internationally and affirms market demand for our portfolio of superior GoodHemp varieties. We’re proud to partner with a well-respected distributor like Tritium 3H to bring our CBD dominant, short day varieties to Canada’s industrial hemp growers.”

Continued Plavan, “Our GoodHemp varieties were field-tested extensively in regional and national trials by the T3H and Arcadia teams. Working closely with T3H, we expect AOSCA certification in mid-December, Health Canada certification in February and significant commercial sales in the spring prior to the planting season.”

Added T3H CEO Jayme Hunter, “We’re pleased to add Arcadia’s high CBD, early maturing varieties to our portfolio. They’ve performed extremely well in our field trials allowing us to offer field proven, feminized, and compliant hemp genetics appropriate for all of Canada’s unique climatic regions. Arcadia’s genetics will provide market leading value to Canadian industrial hemp growers.”

For more information about GoodHemp’s unique seed varieties, visit www.growgoodhemp.com.

About Arcadia Biosciences
Arcadia Biosciences (Nasdaq: RKDA) is a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients. The company’s GoodHemp^TM seed catalog delivers genetically superior hemp seeds, transplants and extracts, applying the company’s proprietary crop innovation technology, ArcaTech™, to an emerging crop. The company’s GoodWheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. For more information, visit www.arcadiabio.com.

About Tritium 3H
Tritium 3H works collaboratively with breeders, producers and end users to bring well adapted hemp varieties with superior performance traits to market. It’s the goal of T3H to maximize value and return for partners at each step of the supply chain. For more information, visit www.growtritium.com.

Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the distribution agreement and the impact of that on Arcadia’s business and financial results. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: the company’s and its partners’ ability to develop commercial products incorporating its traits and to complete the regulatory review process, including AOSCA certification, for such products; the adequacy of hemp seed demand and pricing to support our projections; the company’s compliance with laws and regulations that impact the company’s business, and changes to such laws and regulations; the potential impact of COVID-19 on our business; and the company’s future capital requirements and ability to satisfy its capital needs. Further information regarding these and other factors that could affect the company’s financial results is included in filings the company makes with the Securities and Exchange Commission from time to time, including the section entitled “Risk Factors” and additional information set forth in its Form 10-K for the year ended December 31, 2019 and other filings. These forward-looking statements speak only as of the date hereof, and Arcadia Biosciences, Inc. undertakes no duty to update these forward-looking statements.

LinkedIn: Arcadia Biosciences
Twitter: @ArcadiaAg

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-signs-hemp-distribution-agreement-with-tritium-3h-301179507.html

SOURCE Arcadia Biosciences, Inc.

ELKHART, Ind., Nov. 24, 2020 /PRNewswire/ — Patrick Industries, Inc. (NASDAQ: PATK) (“Patrick” or the “Company”) announced today that it has appointed Jake Petkovich as Executive Vice President of Finance, Chief Financial Officer (“CFO”), and Treasurer of the Company, effective immediately. 

“After a thoughtful and diligent search for a candidate whose values, energy, passion, talent, and expertise align with Patrick’s core values and business needs, we are very excited to welcome Jake on board to lead the Company’s finance function, as well as manage relationships with our financial institutions, shareholders, analysts and other key stakeholders,” said Andy Nemeth, President and Chief Executive Officer of Patrick.  “Jake brings a wealth of financial, strategic and M&A experience, and I am confident he will provide the leadership necessary to continue to help us drive and execute on our strategic growth plan and create and promote shareholder value. Jake joins the Company from Wells Fargo Securities, where his deep expertise in investment banking, capital markets, and leveraged finance brings synergy, talent, and additional depth to our team.” 

Mr. Petkovich commented, “I am both excited and humbled to be joining the Patrick family and look forward to working with the entire team to further enhance the Company’s financial and operational performance, play a key role in driving the execution of Patrick’s strategic growth initiatives, and maximize growth and potential for all of our stakeholders.”

Prior to joining Patrick, Mr. Petkovich served as Managing Director in the Leveraged Finance Group of Wells Fargo Securities and predecessor Wachovia Securities from 2004 to 2020, performing in various senior leadership roles responsible for leading, underwriting, structuring and arranging financing solutions to support issuers’ access to the capital markets for acquisition financings, recapitalizations, refinancings and restructurings. Prior to his banking and finance career, Mr. Petkovich served as an infantry officer in the United States Army from 1995 to 2002, leading soldiers in both domestic and overseas deployment assignments. He earned a BA in Accounting from Washington and Jefferson College and an MBA with a concentration in finance from the College of William and Mary. 

“We would also like to thank John Forbes, a long-time member of Patrick’s Board of Directors who has served as Interim CFO since June 2020, for all of his efforts and leadership in providing a seamless transition and allowing us the time and patience to conduct a thorough and disciplined search process,” said Mr. Nemeth. “John’s contributions were many and invaluable. We are grateful to have had the opportunity to work with John as we continue to advance our organizational goals and objectives. John will remain in his role as a Director and will work with the Company to support an orderly transition over the next 60 days.”

About Patrick Industries, Inc.  
Patrick Industries, Inc. is a major manufacturer and distributor of component products and building products serving the recreational vehicle, marine, manufactured housing, residential housing, high-rise, hospitality, kitchen cabinet, office and household furniture, fixtures and commercial furnishings, and other industrial markets and operates coast-to-coast in various locations throughout the United States and in Canada, China and the Netherlands. Patrick’s major manufactured products include decorative vinyl and paper laminated panels, countertops, fabricated aluminum products, wrapped profile mouldings, slide-out trim and fascia, cabinet doors and components, hardwood furniture, fiberglass bath fixtures and tile systems, thermoformed shower surrounds, specialty bath and closet building products, fiberglass and plastic helm systems and component products, wiring and wire harnesses, boat covers, towers, tops and frames, electrical systems components including instrument and dash panels, softwoods lumber, interior passage doors, air handling products, RV painting, slotwall panels and components, aluminum fuel tanks, and CNC molds and composite parts and other products. The Company also distributes drywall and drywall finishing products, electronics and audio systems components, wiring, electrical and plumbing products, appliances, cement siding, raw and processed lumber, FRP products, interior passage doors, roofing products, tile, laminate and ceramic flooring, shower doors, furniture, fireplaces and surrounds, interior and exterior lighting products, and other miscellaneous products, in addition to providing transportation and logistics services.

Cautionary Statement Regarding Forward-Looking Statements
This press release contains certain statements related to future results, our intentions, beliefs and expectations or predictions for the future, which are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any projections of financial performance or statements concerning expectations as to future developments should not be construed in any manner as a guarantee that such results or developments will, in fact, occur. There can be no assurance that any forward-looking statement will be realized or that actual results will not be significantly different from that set forth in such forward-looking statement. Information about certain risks that could affect our business and cause actual results to differ from those expressed or implied in the forward-looking statements are contained in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, and in the Company’s Forms 10-Q for subsequent quarterly periods, which are filed with the Securities and Exchange Commission (“SEC”) and are available on the SEC’s website at www.sec.gov. Each forward-looking statement speaks only as of the date of this press release, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date on which it is made.

View original content to download multimedia:http://www.prnewswire.com/news-releases/patrick-industries-inc-appoints-jake-petkovich-as-chief-financial-officer-301179719.html

SOURCE Patrick Industries, Inc.

NEW YORK, Nov. 24, 2020 /PRNewswire/ — Meredith Corporation’s PEOPLE, the leading multiplatform entertainment brand, ubiquitous and still at the center of pop culture conversation more than 46 years since its launch, and iHeartMedia, the nation’s No. 1 audio company reaching nine out of ten Americans every month, announce PEOPLE editor Janine Rubenstein as host of PEOPLE Every Day, the new Monday-Friday podcast that is set to premiere with Macy’s, one of the nation’s premier omni-channel fashion retailers, as the exclusive launch sponsor on February 1 on iHeartRadio and all major podcast platforms.

Rubenstein appears regularly on broadcast entertainment and morning shows where she contributes expert commentary on the latest news and PEOPLE feature stories. For the past nine years she has reported and edited breaking news, music features (she interviewed Lenny Kravitz, Mariah Carey, Jon Bon Jovi, and John Legend, to name a few), human interest, style, and contributed to PEOPLE’s popular franchises Sexiest Man Alive and the Beautiful Issue, as well as co-hosted the PEOPLE & Entertainment Weekly Red Carpet Live streaming events during awards season. Prior to joining PEOPLE, the San Francisco native reported news and entertainment at Essence, and served as a reporter/writer at the legendary Cape Times newspaper in South Africa, where she covered crime and local news stories in Cape Town during the 2010 World Cup Games.

“I couldn’t be more excited to host the new PEOPLE Every Day podcast,” said Rubenstein. “As a lifelong news and entertainment enthusiast, I look forward to engaging the brand’s vast audience – and welcoming new audiences — on this exciting platform, where I’ll be breaking down the biggest and best stories of the day.”  In addition, she will step into the role of Editor-at-Large, where she will continue to write, report, and oversee select editorial projects for PEOPLE.

As host of PEOPLE Every Day, which is co-produced by PEOPLE and iHeartRadio, Rubenstein will bring the PEOPLE newsroom to life as a daily escape. Listeners will have access to behind the scenes news spanning celebrity and entertainment, inspiring human-interest features, true crime, style and beauty, sneak peeks, and more. Episodes will be distributed by the iHeartPodcast Network and will feature the biggest stories of the moment, presented with in-depth explainers, expert interviews, and exclusive reporting.

“PEOPLE Every Day will be unlike any other daily podcast the audience has heard – fresh, inspiring, enlightening and fun – and we know that Janine’s incredible skill as a journalist and commentator along with iHeart’s award-winning producers will make this show a truly compelling daily habit for our audiences,” said Will Lee, SVP, Digital, Meredith Entertainment Group.

“We are thrilled to have Janine on board to host PEOPLE Every Day,” said Conal Byrne, President, iHeartPodcast Network. “Her warmth and energy on the mic, along with her experience covering entertainment, style, celebrity, sports, breaking and really all types of human-interest news over the last decade makes her a perfect fit to bring this new daily podcast to life.”

About PEOPLE

Meredith Corporation’s (NYSE: MDP) PEOPLE revolutionized personality journalism when it launched as a weekly in 1974 with a mission to celebrate extraordinary people doing ordinary things and ordinary people doing extraordinary things.  Ubiquitous and still at the center of pop culture more than 46 years later, the PEOPLE brand is accessible across all media and platforms (print, digital, video, OTT, mobile, social) bringing more than 100 million consumers a unique mix of breaking entertainment news, exclusive photos, video, unparalleled access to the red carpet, celebrities, and in-depth reporting on the most compelling newsmakers of our time. An essential component of PEOPLE’s editorial vision remains human interest stories, which touch and often mirror the lives of our passionate audience. ComScore ranks the PEOPLE/Entertainment Weekly Digital Network No. 1 in the entertainment news category. PeopleTV, the advertiser-supported OTT streaming service from PEOPLE and Entertainment Weekly that launched in 2016, features original series and specials focusing on celebrity, red carpet, pop culture, lifestyle and human-interest stories. PEOPLE is an award-winning 24/7 news organization headquartered in NYC with reporters worldwide. For more information visit PEOPLE.com and follow @people on Twitter and Instagram, @peoplemag on Facebook, and the PEOPLE channel on YouTube and on Snapchat’s Discover.

About iHeartMedia

iHeartMedia (NASDAQ: IHRT) is the number one audio company in the United States, reaching nine out of 10 Americans every month – and with its quarter of a billion monthly listeners, has a greater reach than any other media company in the U.S. The company’s leadership position in audio extends across multiple platforms, including more than 850 live broadcast stations in over 160 markets nationwide; through its iHeartRadio digital service available across more than 250 platforms and 2,000 devices; through its influencers; social; branded iconic live music events; other digital products and newsletters; and podcasts as the #1 commercial podcast publisher. iHeartMedia also leads the audio industry in analytics, targeting and attribution for its marketing partners with its SmartAudio product, using data from its massive consumer base. Visit iHeartMedia.com for more company information.

About Macy’s

Macy’s is America’s Department Store. For more than 160 years, Macy’s, the largest retail brand of Macy’s, Inc., has served generations at every stage of their lives. Macy’s customers come to us for fashion, value and high-quality products. We are proud of our heritage and the unique role we play in American culture and tradition. We celebrate occasions big and small and have created decades of memorable experiences through Macy’s 4th of July Fireworks® and Macy’s Thanksgiving Day Parade®, as well as spectacular fashion shows, culinary events, flower shows, and celebrity appearances. With the collective support of our customers and colleagues, Macy’s helps make a difference in every market we serve, supporting local and national charities through funding and volunteer service. With fashion, value and celebration as our guide, Macy’s makes life shine brighter for our customers, colleagues, and communities.

View original content to download multimedia:http://www.prnewswire.com/news-releases/people-and-iheartmedia-name-janine-rubenstein-host-of-people-every-day-podcast-301179305.html

SOURCE PEOPLE

Amended US Licensing Agreement Allows for US Expansion

VANCOUVER, BC, Nov. 24, 2020 /PRNewswire/ – (CSE: OVAT) (OTC: OVATF) – Ovation Science Inc. (“Ovation” or the “Company”) announces that by mutual agreement its Licensing Agreement of November 10, 2017 with Lighthouse Strategies, LLC. (“Lighthouse”) has been amended in order to facilitate Ovation’s prospective expansion plans into additional states beyond Nevada in the US (the “Amendment”). Due to the continuing refinement of Ovation’s business strategy for its cannabis products and because of Lighthouse’s success in Nevada with Ovation’s topical cannabis products, Lighthouse will focus its efforts on expanding its leadership in topicals in Nevada for a period of one year; renewable by mutual consent.  In connection with the Amendment, Lighthouse will have the exclusive rights to Ovation’s topical products containing THC and sold exclusively in Nevada dispensaries and the non-exclusive rights to Ovation’s topical CBD products in Nevada only. Along with the previous terms of the Agreement, the Amendment specifies a Minimum Quarterly payment.

“The cannabis industry has evolved tremendously in the past three years when we first introduced Ovation’s formulations into the US marketplace and notably even in the past two weeks following the US election.” said Mr. Terry Howlett, President of Ovation. “We are focused on creating greater shareholder value and therefore are excited to now have the opportunity to seek additional licensees across the United States with this new Amendment in place. Our strategic growth plan is to secure multi-state operators through-out the US that have the infrastructure and marketing expertise in their regions to launch Ovation’s CBD and THC topical products of which we have over 25 formulations developed including our beauty line ARLO CBD Beauty and our wellness line Invibe®MD. We have already proven the superiority of our products in Nevada with Lighthouse and believe this can be duplicated and expanded into other states.” He added, “We also realize that there are Canadian and European companies that are seeking a foot-hold into the US market with science-based cannabis topical products and we will pursue those opportunities as well.”

The recent changes to the cannabis market have highlighted greater opportunity for expanded US distribution of Ovation’s patented topical and transdermal products. The pandemic has not slowed down overall cannabis sales, in fact, most US states and Canada showing record sales since the spring. (Sources: NewCannabisVentures.com, Sept 2020 “July Cannabis Sales Surge in 5 Western States” and Statista.com: www.statista.com/statistics/1045766/cannabis-store-sales-canada/). The election results showed that the legalization of marijuana continues to be widely accepted as shown by the recent unanimous approval of five more states legalizing medical or recreational marijuana (Arizona, Mississippi, Montana, New Jersey, and South Dakota).  Additionally, there are over 90 bills in front of Congress including a comprehensive Democratic initiative called the More Act which could legalize cannabis federally. (TheFreshToast.com, Oct. 22, 2020: “Why The 2020 Election Could Change Everything For The Cannabis Industry”.)  This new legislation will be decidedly impactful for the cannabis industry with edibles and topicals standing to gain significantly from these changes to federal restrictions (Source: Happi.com 04.10.20 “MarketWatch: CBD Edibles & Topicals Expected to Gain Share of Cannabis Market”).   

Medical marijuana is now legal in 36 states plus the District of Columbia with 15 states having both medical and recreational cannabis approved. According to Statista.com, by 2024 retail sales of marijuana could reach as high as US$ 12 billion in sales, with medical marijuana sales expected to double. The CBD skin care market, one of markets where Ovation is position, is projected to reach US$959 million by 2024 (Source: Prohibition Partners: “The Impact Series: Disrupting Beauty.”)

For information about Ovation Science products visit
: https://ovationscience.com/products/
.

About Ovation Science Inc.

Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including DermSafe® hand sanitizer and its two CBD product lines ARLO CBD Beauty and InVibe® MD, all made with patented Invisicare® skin delivery technology. The technology enhances the delivery of ingredients to and through the skin and is protected by patents in eleven countries. With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation’s management and science team have created a unique pipeline of over twenty-five patent-protected medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas. Ovation earns revenues from licensing and development fees, royalties, the sale of Invisicare to its licensees along with revenue from its own product sales. Ovation has offices in Vancouver, BCCanada and Las Vegas, Nevada, USA. Ovation trades on the CSE under the symbol OVAT and in the USA on OTC markets under the symbol OVATF. Visit our website www.ovationscience.com for more information.

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular there is no assurance of expansion of its products in the US or elsewhere nor that a change in legislation will occur or have an impact. There are no guarantees of future performance. Ovation Science Inc. cautions that all forward looking statements are inherently uncertain and that actual results may be affected by a number of material factors, many of which are beyond Ovation Science Inc.’s control. Accordingly, readers should not place undue reliance on the forward-looking information. Ovation disclaims any obligation to revise or update any such forward-looking information to reflect future results, events or circumstances, except as required by law. 

Neither the Canadian Securities Exchange, OTC Markets nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:http://www.prnewswire.com/news-releases/ovation-science-seeks-greater-us-distribution-as-the-cannabis-market-continues-to-grow-301179342.html

SOURCE Ovation Science Inc.

BARCELONA, Spain, Nov. 24, 2020 /PRNewswire/ — AlmirallShare, the open innovation platform of Almirall, S.A. (ALM), announces two new collaborations with the University of South Australia and the Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau to find new pathways for the treatment of skin cancer and atopic dermatitis.

The collaboration with Prof. Tarl Prow, Research Professor at Future Industries Institute of the University of South Australia, is focused on generating knowledge about a common type of skin tumor. The aim is to elucidate the molecular mechanisms underlying squamous cell carcinoma and the modulation by a specific treatment. “We are excited to be joining forces with Almirall in this collaborative research project that allows us to establish synergies between different groups to follow our commitment to fight skin cancer. Pairing our deep knowledge of a common type of skin tumor with Almirall’s leading expertise in medical dermatology could reimagine the treatment options for people with skin carcinoma,” said Prof. Tarl Prow.

The project led by Prof. Dr. Lluís Puig, Director of Dermatology Department, and Prof. Silvia Vidal, Coordinator of Inflammatory Diseases Research Area, at Hospital de la Santa Creu i Sant Pau will focus on the understanding of biosignatures operating in atopic dermatitis in the different stages of the disease and in response to systemic therapy. “We strongly believe that this collaboration will boost new findings on atopic dermatitis, and it is a further step in future research on new treatments. We are very pleased to be joining forces with a leading medical dermatology company like Almirall,” stated Prof. Dr. Lluís Puig and Prof. Silvia Vidal.

“We are very pleased to start with these two new collaborations and establish close successful partnerships with them. We continue working to empower scientists to improve skin health and fostering collaboration projects with partners worldwide to make a real difference for patients living with skin conditions,” said Maribel Crespo, AlmirallShare leader

AlmirallShare is responsible for approximately 50% of the private-public collaborations driven by Almirall. It facilitates collaborations in dermatological research and accelerate the generation of new treatments for skin conditions. Scientists from anywhere in the world may submit their proposals to submit their proposals responding to the current open calls on sharedinnovation.almirall.com.

 

View original content:http://www.prnewswire.com/news-releases/almirall-announces-collaborations-with-the-university-of-south-australia-and-fundacio-institut-de-recerca-de-lhospital-de-la-santa-creu-i-sant-pau-301179393.html

SOURCE Almirall, S.A.

OMAHA, Neb., Nov. 24, 2020 /PRNewswire/ — Lance Fritz, chairman, president and chief executive officer, of Union Pacific Corporation (NYSE: UNP), will address the Credit Suisse 8^th Annual Virtual Industrials Conference on Thursday, December 3, 2020, at 8:50 a.m. ET.

A live webcast of the presentation will be available in the investor relations section of Union Pacific’s website at www.up.com/investor. A replay of the audio webcast will be available shortly thereafter.

ABOUT UNION PACIFIC
Union Pacific (NYSE: UNP) delivers the goods families and businesses use every day with safe, reliable and efficient service. Operating in 23 western states, the company connects its customers and communities to the global economy. Trains are the most environmentally responsible way to move freight, helping Union Pacific protect future generations. More information about Union Pacific is available at www.up.com.

www.up.com

www.facebook.com/unionpacific

www.twitter.com/unionpacific

View original content to download multimedia:http://www.prnewswire.com/news-releases/union-pacific-corporation-ceo-lance-fritz-to-address-the-credit-suisse-8th-annual-virtual-industrials-conference-301179247.html

SOURCE Union Pacific Corporation

NORTH CHICAGO, Ill., Nov. 24, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) will participate in the Evercore ISI Virtual HealthCONx Conference on Wednesday, December 2 at 1:40 p.m. CT and the Piper Sandler Virtual Healthcare Conference on Thursday, December 3 at 10 a.m. CT. Michael Severino, M.D., vice chairman and president, and Robert A. Michael, executive vice president and chief financial officer, will present at both conferences.

A live audio webcast of each presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the sessions will be available later that day.

About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-evercore-isi-conference-and-piper-sandler-healthcare-conference-301179192.html

SOURCE AbbVie